Where healthcare
excellence drives
commercial outcomes

We advise healthcare businesses on M&A and capital strategy
across IT, pharma and health services, balancing clinical
integrity with investor outcomes.

Focused on
outcomes

Years of sector experience

100

Companies advised across hospitals,
clinics, and HealthTech

Countries advised and transacted in

cokile-ceoi-GsJwAFOtAG4-unsplash-2-scaled-2560x1881

Sector Expertise

Drawing on experience across technology-enabled care and data-led services, we deliver cross-border outcomes balancing medical credibility and investor value.

Pharmaceuticals & Life Sciences	HealthTech	Hospitals & Clinics
BioTech	Medical Devices	Clinical Research

Select Transactions

Trusted to lead complex, global transactions

We unlock value for our clients – guiding strategic decisions with precision,
discipline, and a relentless focus on exceptional outcomes.

Acquired by

A portfolio company of

Novistra Capital advised Cloud Development Resources on its majority sale to emids

CDR engaged Novistra Capital to lead a targeted process culminating in its sale to emids, aligning complementary strengths in low-code innovation and healthcare digital transformation.

Outcome: Established the healthcare industry’s first dedicated low-code practice

Majority investment in

Novistra Capital advised Excelra on its majority investment in Anilitiks

Served as exclusive buy-side advisor to Excelra on its acquisition of Anilitiks, strengthening Excelra’s HEOR and real-world evidence analytics capabilities for global pharmaceutical clients.

Outcome: Expanded Excelra’s data-driven Life Sciences solutions portfolio

License agreement with

Novistra Capital advised IDD Biotech on its license agreement with Enzene Biosciences, a subsidiary of Alkem Labs

IDD Biotech appointed Novistra Capital to structure and negotiate a licensing deal for its CD19 oncology asset, securing an ideal manufacturing and innovation partner in...

Outcome: Exclusive licensing agreement with Enzene Biosciences completed

Merged with

Novistra Capital advised ACN Healthcare on its merger with Rapid Care’s RCM business

Advised ACN Healthcare on its merger with the RCM business of Rapid Care Group, creating a scaled healthcare outsourcing platform with multi-city delivery and expanded...

Outcome: Merger created a scaled, integrated healthcare RCM platform

Acquired by

Novistra Capital advised Pacific BPO on its sale to Access Healthcare

Exclusive advisor to Pacific BPO on its sale to Access Healthcare, creating one of the largest integrated healthcare revenue cycle management platforms globally.

Outcome: Completed sale of Pacific BPO to Access Healthcare

View All Transactions

Our Leadership